Biapenem | Interleukin Related interleukin-related.com

Product Name :
Biapenem

Search keywords :
Biapenem

drugId :
null

Target Vo:
Bacterial penicillin-binding protein

Target Vo Short Name :
PBPs

Moa_Name:
Bacterial penicillin-binding protein inhibitors

First Approval Country :
Japan

First Approval Date Filter:
2001

Origin Company_Name :
Meiji Seika Pharma Co Ltd

Active Company_Name :
Meiji Seika Pharma Co Ltd

Active Indication_Name:
Bacterial Infections

In Active Indication_Name:
Respiratory Tract Infections

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD80 Antibody (YA3386) Epigenetics
ATF4 Rabbit pAb custom synthesis
MYSM1 Antibody: MYSM1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 95 kDa, targeting to MYSM1. It can be used for WB,IHC-P assays in the background of Human, Mouse.

Author: Interleukin Related

Related Posts